Eyenovia Inc reports results for the quarter ended March 31 - Earnings Summary

• Eyenovia Inc EYEN.OQ reported a quarterly adjusted loss of $1.63​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $-18.40. The lone analyst forecast for the quarter was for a loss of $9.60 per share.

• Revenue rose 275% to $15.00 thousand from a year ago; analysts expected $400.00 thousand.

• Eyenovia Inc's reported EPS for the quarter was a loss of $1.59​.

• Eyenovia Inc shares had risen by 2.7% this quarter and lost 90.3% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is "buy."

• Wall Street's median 12-month price target for Eyenovia Inc is $160.00

This summary was machine generated from LSEG data May 19 at 10:55 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)